Scrip
UMN's cell cultured H5N1 vaccine moves forward
22 October 2009
Ian Haydock
Please Login to read the full article.
22 October 2009
Ian Haydock
The Japanese bioventure UMN Pharma has begun a Phase II development programme for UMN-0501, its novel recombinant human vaccine for the H5N1 form of influenza.
Results from the two-centre Japanese trial, to be carried out in 90 healthy adults aged 20-40 years, are expected next February....
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
